Uses of Amucap 30mg

Amucap is a product of Mebiphar Pharmaceutical and Biomedical Joint Stock Company with the main ingredient Ambroxol 30mg.
Active ingredient Ambroxol is essentially a metabolite of Bromhexin, so it has the same effect as Bromhexin. The active ingredient Ambroxol in the drug Amucap 30mg has an expectorant and mucolytic effect, but the mechanism is unclear. Few documents have documented Ambroxol's ability to improve symptoms and reduce the number of exacerbations in bronchitis. It is reported that Amucap is quite effective in patients with mild to moderate obstructive pulmonary disease, but the benefit in patients with severe obstructive pulmonary disease is not clear.
Amucap 30mg product is in the form of hard capsules, packed in a box of 10 blisters x 10 tablets.

Active ingredient Ambroxol has the ability to regulate mucus secretion and expectoration by severing disulfur bridges of glycoproteins. Therefore, Amucap 30mg is indicated for use in the following cases:
Acute and chronic respiratory diseases accompanied by abnormal bronchial secretions, especially including acute exacerbations of chronic bronchitis, chronic bronchial asthma or asthmatic bronchitis; Prevention of pulmonary complications in postoperative patients. Pharmacokinetic characteristics of the drug Amucap 30mg:
Ambroxol is well absorbed orally, maximum plasma concentrations are reached after about 2 hours of taking the drug. Bioavailability of Amucap 30mg is about 70%; The volume of distribution of Amucap 30mg is high, which demonstrates significant extravascular diffusion; The half-life of the drug Amucap is about 7.5 hours; The major route of elimination of Ambroxol is in the urine as 2 glucuronic conjugated metabolites.

Patients should take Amucap 30mg with a sufficient amount of water after meals with specific doses as follows:
Adults and children over 10 years old: 1 Amucap 30mg tablet / time, 3 times / day; Children 5 - 10 years old: Take 1⁄2 tablets of Amucap 30mg / time, 3 times a day; In case of prolonged use, reduce the number of times of taking Amucap to 2 times/day. Note: The dosage of Amucap 30mg mentioned is for reference only. Dosage in each individual patient depends on the doctor's prescription as well as the condition and the progress of the disease. Therefore, to get the correct dosage, the patient needs to consult the treating doctor.

Patients using Amucap 30mg may experience some unwanted effects (ADRs). In which, there are often mild complications, mainly related to the digestive system such as heartburn, indigestion, sometimes nausea, vomiting.
Some uncommon and rare undesirable effects of Amucap 30mg:
Allergic reactions, mainly skin rash; Severe acute anaphylactic-type reaction, but still uncertainly related to Ambroxol; Dry mouth ; Increase liver enzymes. When experiencing side effects of Amucap 30mg, the patient should stop using it and notify the treating doctor or go directly to the nearest medical facility for timely intervention.

Before using any medicine, including Amucap 30mg, the patient should carefully read the instructions for use and the information below.
Cases of contraindications to Amucap 30mg:
Allergy or hypersensitivity to active ingredient Ambroxol or any of the ingredients in this product; Stomach or duodenal ulcer is progressing. Some cautions when using Amucap:
Be especially careful when using Amucap 30mg for people with peptic ulcer disease and cases of hemoptysis because Ambroxol can dissolve fibrin clots. , which in turn leads to re-bleeding; Ability to drive and use machines: There have been no reports on the ability to use machines or drive vehicles with Amucap 30mg; Pregnancy: There is no evidence of toxicity to the fetus when using Amucap 30mg during pregnancy. However, women should be cautious when taking Amucap 30mg in the first 3 months of pregnancy; Lactation: There is no information on the concentration of ambroxol in breast milk. Drug interactions of Amucap 30mg:
Ambroxol can increase the concentration of antibiotics in the lung parenchyma, which includes antibiotics such as Amoxicillin, Cefuroxim, Doxycycline, Erythromycin; In addition, so far there is no information on other adverse interactions of Amucap 30mg in clinical practice.
Ambroxol is an expectorant agent commonly used in acute or chronic respiratory diseases. This active ingredient is in the drug Amucap 30mg. To ensure the effectiveness of treatment and avoid side effects, users need to strictly follow the instructions of the doctor.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.